- RFK Jr. Hires Autism Skeptic To Look Into CDC Autism Data
- New Antibody Shot Could Help Protect Babies From RSV
- Zicam and Orajel Swabs Recalled for Possible Fungal Contamination
- Smartphone App Can Track Huntington’s Disease Symptoms
- Screen Time And Troubled Kids: Is There A Vicious Circle?
- Most People Open To Sharing Smartwatch Health Data With Doctors
- Misconceptions Abound Regarding High Blood Pressure, Poll Finds
- Accelerated Biological Aging Tied To Dementia, Stroke Risk
- Bisexual, Gay and Lesbian Medical Students Less Likely To Finish School
- FDA Approves Polypill Widaplik for Hypertension
Xtoro Approved for Swimmer’s Ear
Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer’s ear, clinically known as acute otitis externa.
The infection of the outer ear and ear canal, most often caused by ear canal bacteria, has typical symptoms including pain, swelling, redness and discharge, the FDA said in a news release.
The drug’s safety and effectiveness were evaluated in a clinical study of more than 1,200 people, aged 6 months to 85 years. The most common side effects were ear itching and nausea.
Xtoro is produced by Alcon Laboratories, based in Fort Worth, Texas.
More information
The FDA has more about this approval.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.
Related
-
FDA Authorizes First AI Platform for Breast Cancer PredictionPlatform can help predict a woman's five-year risk for...
- June 6, 2025
-
Judge Says Transgender Inmates Must Have Access to Hormone TherapyA federal judge has ruled that transgender inmates in...
- June 4, 2025
-
High Insulin Linked To Irregular PeriodsElevated insulin levels could be causing irregular menstrual bleeding...
- June 4, 2025
-
Breast Cancer Screening In Women’s 40s Can Save Lives, Study SaysStarting breast cancer screening in women’s early 40s will...
- June 3, 2025
